Elevation Oncology, Inc. (ELEV) Tops Q1 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- S&P 500, Nasdaq set for lower open as AI stocks slide on debt concerns
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent oil slips as US weighs easing sanctions on Russia's 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
Tweet
Share
E-mailGet Alerts ELEV Hot Sheet
Join SI Premium – FREE
Elevation Oncology, Inc. (NASDAQ: ELEV) reported Q1 EPS of ($0.23), $0.06 better than the analyst estimate of ($0.29).
For earnings history and earnings-related data on Elevation Oncology, Inc. (ELEV) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FMC tumbles 35% after slashing Q3 outlook over weak demand and inventory issues
- Barclays bullish on Crocs, sees multi-year growth story
- CMC shares rise 4% on fourth quarter earnings beat
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
